Viral Hepatitis & Liver Cancer: Trends, Risks, and Prevention | St. Joseph’s Healthcare System

Contents

Hepatitis C replication Image/ GrahamColm

Hepatitis C replication. Image: GrahamColm

Viral Hepatitis & Liver Cancer: Key Facts

According to the Annual Report to the Nation on the Status of Cancer (1975–2012), overall cancer mortality rates continue to decline.
However, liver cancer is a critical exception. Unlike many other cancer types, both incidence and mortality rates for liver cancer are rising.

From 2003 to 2012, overall cancer death rates decreased by approximately 1.5% per year. In contrast, liver cancer death rates increased faster than any other major cancer site.

Key Findings on Liver Cancer

  • Liver cancer incidence increased by an average of 2.3% per year between 2008 and 2012.
  • Mortality rates rose by 2.8% per year in men and 3.4% per year in women.
  • Men are diagnosed with liver cancer nearly twice as often as women.
  • Highest incidence rates were observed among American Indian/Alaska Native and Asian/Pacific Islander men.

Major Risk Factors

A significant contributor to liver cancer in the United States is chronic viral hepatitis.

  • Hepatitis C (HCV): Responsible for over 20% of liver cancer cases.
  • Hepatitis B (HBV): Especially prevalent among Asian and Pacific Islander populations.
  • Obesity and type 2 diabetes: Can lead to cirrhosis and liver cancer.
  • Excessive alcohol consumption: Linked to 8–16% of liver cancer deaths.

People born between 1945 and 1965 are at the highest risk for HCV infection and should receive one-time screening.

As noted by the National
Cancer Institute,
vaccination and early detection remain among the most effective cancer prevention strategies.

Prevention & Early Detection

  • Universal hepatitis B vaccination beginning at birth
  • Hepatitis B and C testing for high-risk populations
  • Timely antiviral treatment, reducing liver cancer risk by up to 80%
  • Reducing alcohol use and managing metabolic conditions

Liver Cancer Statistics

Indicator Data
Annual incidence increase ~2.3%
Mortality increase (men) 2.8% per year
Mortality increase (women) 3.4% per year
HCV-related liver cancers >20%

FAQ: Viral Hepatitis & Liver Cancer

Can liver cancer be prevented?

Yes. Vaccination, screening, and antiviral treatment can dramatically reduce liver cancer risk.

Why is hepatitis C so dangerous?

Hepatitis C often has no symptoms for decades, silently damaging the liver until cancer or cirrhosis develops.

Who should be tested for hepatitis?

Everyone born between 1945–1965, people with risk factors, and those from high-prevalence regions.

Is hepatitis C curable?

Yes. Modern treatments can cure hepatitis C in 8–12 weeks, reducing liver cancer risk by up to 75%.

St. Joseph’s Regional Medical Center – Center for Liver, Pancreas and Biliary Diseases


Related Posts:

➤